Tami Tillotson Martin is VP at SUPERNUS PHARMACEUTICALS, INC. (SUPN). They have made 6 open-market trades across 1 company since 2012, most recently 2024-02-23.
CIK 0001539494
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $13K since 2012, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SUPN | 87,418 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2024-02-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SUPN | SELL · 10b5-1 | 2024-01-10 | 2024-01-12 | $27.91 | $223K | +3.0% | +1.2% | +14.2% |
| SUPN | SELL | 2023-08-30 | 2023-09-01 | $32.00 | $259K | -9.0% | -15.7% | -15.3% |
| SUPN | SELL | 2023-08-25 | 2023-08-29 | $31.59 | $324K | -5.5% | -10.9% | -14.0% |
| SUPN | SELL | 2022-08-22 | 2022-08-23 | $35.98 | $360K | -2.4% | -6.6% | -1.8% |
| SUPN | SELL | 2022-08-04 | 2022-08-05 | $32.98 | $330K | +4.2% | +6.0% | +6.7% |
| SUPN | SELL | 2021-04-13 | 2021-04-14 | $30.98 | $387K | -0.4% | -4.6% | -13.1% |
| SUPN | BUY | 2012-05-04 | 2012-05-07 | $5.00 | $13K | -17.4% | -0.2% | -0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.